Phase 2b clinical trial data showing the evaluation of vamorolone in boys with Duchenne Muscular Dystrophy (DMD) show effectiveness in primary and secondary research objectives. Also, this research treatment has a good reputation in terms of safety conditions.
برای افزودن متن مورد نظرتان اینجا کلیک کنید